HIF-1α inducing exosomal microRNA-23a expression mediates the cross-talk between tubular epithelial cells and macrophages in tubulointerstitial inflammation
HIF-1α inducing exosomal microRNA-23a expression mediates the cross-talk between tubular epithelial cells and macrophages in tubulointerstitial inflammation
复制标题
HIF-1α 诱导外泌体 microRNA-23a 表达介导肾小管间质炎症中肾小管上皮细胞和巨噬细胞之间的串扰。
DOI:
10.1016/j.kint.2018.09.013
复制
发表时间:
2019-02-01
影响因子:
19.6
通讯作者:
Liu, Bi-Cheng
中科院分区:
文献类型:
--
作者:
Li, Zuo-Lin;Lv, Lin-Li;Liu, Bi-Cheng
Hypoxia promotes tubulointerstitial inflammation in the kidney. Although hypoxia inducible factor-1 alpha (HIF-1 alpha) is a master regulator of the response to hypoxia, the exact mechanisms through which HIF-1 alpha modulates the induction of tubulointerstitial inflammation are still largely unclear. We demonstrated tubulointerstitial inflammation and increased tubular HIF-1 alpha expression in murine models of ischemia/reperfusion injury and unilateral ureteral obstruction. Increased expression of HIF-1 alpha in tubular epithelial cells was associated with selective shedding of microRNA-23a (miRNA-23a)-enriched exosomes in vivo and systemic inhibition of miRNA-23a prior to ischemia/reperfusion injury attenuated tubulointerstitial inflammation. In vitro, uptake of miRNA-23a-enriched exosomes by macrophages triggered their reprogramming into a pro-inflammatory state via suppression of the ubiquitin editor A20. To confirm the effect of miRNA-23a-containing exosomes on tubulointerstitial inflammation, we exposed tubular epithelial cells to hypoxic conditions to promote the release of miRNA-23a-containing exosomes. Injection of these miRNA-23a-enriched exosomes into uninjured renal parenchyma resulted in increased inflammatory infiltration in vivo. Taken together, our studies demonstrate that the HIF-1 alpha-dependent release of miRNA-23a-enriched exosomes from hypoxic tubular epithelial cells activates macrophages to promote tubulointerstitial inflammation. Blockade of exosomemediated miRNA-23a transfer between tubular epithelial cells and macrophages may serve as a novel therapeutic approach to ameliorate tubulointerstitial inflammation.